Medichec

5
Medichec
Medichec is an iOS app from Health Innovation Network in the Health & Fitness category, currently rated — across few ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Quality Score is 5: Niche (micro-niche or pre-traction stage). For a Health & Fitness app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Health & Fitness complexity ×1.40 | +$20K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| 🏷 Health & Fitness category multiple | +10% |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Pre-traction · 31/100INDIE TIERlimited signal- 💰 Revenue: Modest — $406 - $2542/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 915d ago — possibly dormant.
- ⚠️ Risk: Moderate — dormant (915d since update).
💰 Forecast Revenue / mo
MODEL| Paid app ($0.00)METRIC | +$2,800 | |
| Established app (5y old)METRIC | +$800 | |
| Single-language (English only)METRIC | −$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v1.2.0
- Updated new side effects like constipation, QTc Prolongation, Hyponatraemia and bleeding risk.
- Option to filter by choosing side effects & sort by high to low-severity drugs
Profile & Insights
Identification
- App name
- Medichec
- Developer
- Health Innovation Network
- Bundle ID
- medichec.com
- App Store URL
- Open in App Store
- Category
- Health & Fitness
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $4.0K/mo
- Top-grossing rank
- Outside top 100 in US Health & Fitness
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
Medichec has been designed as an accurate, easy to use tool, to score the anticholinergic effect of widely used medications in healthcare, along with information on whether they may cause dizziness or drowsiness.
Medichec is based on the latest research and up to date scientific information and has been created by senior clinicians and academics in collaboration with healthcare app design experts.… View full description on the official store →
What Worked™ · Development Pipeline
3 EVENTS TRACKEDMulti-Country Performance
Available in 2 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇺🇸 US | 0★ | 0 | — |
| 🇬🇧 GB | 3★ | 4 | 3★ this version |
Track this app’s revenue
FREE📝 Description
95
Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Medichec is a very early-stage iOS app in the health & fitness space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




